Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P50
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025-1.45%
2024-24.15%
2023-148.45%
202239.07%
2021-280.58%
202014.47%
20190.00%